サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1787233

次世代シーケンスライブラリー調製の世界市場

Next-generation Sequencing Library Preparation

出版日
ページ情報
英文 220 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
次世代シーケンスライブラリー調製の世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 220 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

次世代シーケンスライブラリー調製の世界市場は2030年までに41億米ドルに達する

2024年に19億米ドルと推定される次世代シーケンスライブラリー調製の世界市場は、2030年には41億米ドルに達し、分析期間2024-2030年のCAGRは13.4%で成長すると予測されます。本レポートで分析したセグメントの1つであるターゲットゲノムシーケンスは、CAGR 10.4%を記録し、分析期間終了までに14億米ドルに達すると予測されます。全ゲノムシーケンスセグメントの成長率は、分析期間中CAGR 15.8%と推定されます。

米国市場は5億350万米ドルと推定、中国はCAGR12.8%で成長すると予測

米国の次世代シーケンスライブラリー調製市場は、2024年に5億350万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを12.8%として、2030年までに6億3,820万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.9%と11.8%と予測されています。欧州では、ドイツがCAGR 10.1%で成長すると予測されています。

世界の次世代シーケンスライブラリー調製市場- 主要動向と促進要因のまとめ

次世代シーケンスライブラリー調製はどのようにゲノム調査を進めているのか？

次世代シーケンス（NGS）ライブラリ調製は、ゲノム解析における重要なステップであり、研究者はDNAおよびRNAサンプルをハイスループットシーケンスに適したフォーマットに変換することができます。調製プロセスでは、断片化、アダプターライゲーション、増幅、品質管理が行われ、正確で効率的なシーケンスが保証されます。NGS技術は遺伝学に革命をもたらし、精密医療、腫瘍学、感染症研究、農業ゲノミクスなど、さまざまな用途でゲノム、トランスクリプトーム、エピゲノムをより迅速かつコスト効率よく解析できるようになりました。臨床診断におけるNGSの採用が増加していることから、効率性と再現性を高める、より合理的で自動化に適した、スケーラブルなライブラリー調製キットに対する需要が高まっています。さらに、シングルセルシーケンスとロングリードシーケンスの進歩はゲノム解析の限界を押し広げつつあり、複雑なサンプルに合わせたライブラリー調製法の改善が必要とされています。研究者がシーケンスの精度、感度、スループットの向上を目指す中、ライブラリー調製技術は進化を続け、ゲノミクス分野の発展に重要な役割を果たしています。

NGSライブラリー調製技術の採用に影響を与えている課題とは？

その変革の可能性にもかかわらず、NGSライブラリー調製市場は、アクセシビリティ、効率性、費用対効果に影響するいくつかの課題に直面しています。主な懸念事項の1つは、熟練した技術者、高価な試薬、大規模なサンプルハンドリングを必要とする、従来のライブラリー調製法の労働集約的な性質です。サンプル品質や調製効率のばらつきは、シーケンスエラーやデータの信頼性低下につながる可能性があり、強固な品質管理対策が必要となります。もう1つの大きな課題は、ライブラリー調製キットのコストが高いことであり、小規模な研究機関や臨床検査室にとっては法外なコストとなる可能性があります。さらに、低インプットDNAや劣化DNAを含む多様なサンプルタイプの取り扱いが複雑なため、高度に専門化されたプロトコールが必要となり、カスタマイズされたソリューションの必要性が高まっています。臨床検査室はNGSベースの診断のための厳格なコンプライアンス要件を遵守しなければならないため、規制上の課題や標準化の問題が臨床での採用をさらに妨げています。これらの課題を克服するには、自動化、試薬化学、バイオインフォマティクス・ソリューションにおける継続的な技術革新が必要であり、NGSライブラリー調製をより効率的でコスト効率に優れ、幅広いアプリケーションに対応できるスケーラブルなものにする必要があります。

技術革新はどのようにNGSライブラリー調製の将来を牽引しているのか？

技術の進歩により、NGSライブラリー調製の効率と精度が大幅に改善され、サンプル処理とシーケンス品質における重要な課題に対処しています。最もインパクトのある技術革新の1つは、サンプル調製ワークフローの自動化であり、作業時間の短縮、人的ミスの最小化、サンプルスループットの向上です。ロボットリキッドハンドリングシステムとマイクロ流体プラットフォームは、調製プロセスを合理化し、臨床および研究ラボにとってハイスループットシーケンスをより身近なものにしています。イルミナのNexteraテクノロジーなど、トランスポザーゼベースのライブラリー調製法の開発により、DNA断片化とアダプター挿入が簡素化され、調製時間と試薬コストが削減されています。さらに、シングルチューブおよびダイレクトRNAシーケンスアプローチにより、複雑なワークフローが不要になり、トランスクリプトミクス研究の効率が向上しています。分子バーコードとユニーク分子識別子（UMI）の進歩は、PCRバイアスを減らし、低頻度のバリアントを検出することで、シーケンスの精度を高めています。バイオインフォマティクスにおけるAIと機械学習の統合もまた、最適な試薬条件を予測し、データの解釈を改善することによって、ライブラリー調製プロトコルを最適化しています。こうした技術革新が進化を続ける中、NGSライブラリー調製市場は、効率性、拡張性、臨床採用の拡大に向けて態勢を整えています。

何がNGSライブラリー調製市場の成長を牽引しているのか？

次世代シーケンスライブラリー調製市場の成長は、個別化医療に対する需要の増加、疾患研究におけるNGSの応用拡大、自動化と試薬化学における技術進歩など、いくつかの要因によってもたらされます。腫瘍学、感染症、希少遺伝子疾患におけるNGSベースの診断の採用拡大が、より効率的で費用対効果の高いライブラリー調製ソリューションの需要を促進しています。また、シングルセルシーケンスの台頭も市場成長に寄与しています。研究者は、個々の細胞を高感度で解析するために特殊なライブラリー調製法を必要としているからです。さらに、農業ゲノミクス、マイクロバイオーム研究、合成生物学の拡大も市場需要をさらに押し上げています。これらの分野ではゲノム解析にハイスループットシーケンスが利用されているためです。臨床NGSアプリケーションの標準化と規制承認の推進も市場動向を形成しており、メーカーは厳しい診断要件を満たすコンプライアントライブラリー調製キットを開発しています。バイオインフォマティクスとクラウドベースのシーケンスプラットフォームへの投資により、データ管理とアクセシビリティが強化され、NGSが多様な研究および臨床用途に広く利用されるようになっています。シーケンス技術の進歩によりコスト削減と精度向上が進むにつれ、NGSライブラリー調製市場は持続的な成長を遂げ、ゲノム研究と精密医療に革命をもたらすと予想されます。

セグメント

シーケンスタイプ（ターゲットゲノムシーケンス、全ゲノムシーケンス、全エクソームシーケンス、その他のシーケンスタイプ）、製品タイプ（ライブラリー調製試薬・消耗品、ライブラリー調製機器）、用途（創薬・バイオマーカー探索用途、疾病診断用途、がん診断用途、生殖医療診断用途、感染症診断用途、その他疾病診断用途）、最終用途（学術・研究機関最終用途、製薬・バイオテクノロジー企業最終用途、病院・クリニック最終用途、その他最終用途）

調査対象企業の例

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32336

Global Next-generation Sequencing Library Preparation Market to Reach US$4.1 Billion by 2030

The global market for Next-generation Sequencing Library Preparation estimated at US$1.9 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Targeted Genome Sequencing, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Whole Genome Sequencing segment is estimated at 15.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$503.5 Million While China is Forecast to Grow at 12.8% CAGR

The Next-generation Sequencing Library Preparation market in the U.S. is estimated at US$503.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$638.2 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Global Next-Generation Sequencing Library Preparation Market - Key Trends & Drivers Summarized

How Is Next-Generation Sequencing Library Preparation Advancing Genomic Research?

Next-generation sequencing (NGS) library preparation is a critical step in genomic analysis, enabling researchers to convert DNA and RNA samples into formats suitable for high-throughput sequencing. The preparation process involves fragmentation, adapter ligation, amplification, and quality control, ensuring accurate and efficient sequencing. NGS technology has revolutionized genetics, allowing for faster and more cost-effective analysis of genomes, transcriptomes, and epigenomes across various applications, including precision medicine, oncology, infectious disease research, and agricultural genomics. The increasing adoption of NGS in clinical diagnostics is driving demand for more streamlined, automation-friendly, and scalable library preparation kits that enhance efficiency and reproducibility. Additionally, advancements in single-cell sequencing and long-read sequencing are pushing the boundaries of genome analysis, necessitating improved library preparation methods tailored for complex samples. As researchers strive for higher sequencing accuracy, sensitivity, and throughput, library preparation technologies continue to evolve, playing a crucial role in advancing the field of genomics.

What Challenges Are Affecting the Adoption of NGS Library Preparation Technologies?

Despite its transformative potential, the NGS library preparation market faces several challenges that impact accessibility, efficiency, and cost-effectiveness. One of the primary concerns is the labor-intensive nature of traditional library preparation methods, which require skilled technicians, expensive reagents, and extensive sample handling. Variability in sample quality and preparation efficiency can lead to sequencing errors and reduced data reliability, necessitating robust quality control measures. Another major challenge is the high cost of library preparation kits, which can be prohibitive for smaller research institutions and clinical laboratories. Additionally, the complexity of handling diverse sample types, including low-input and degraded DNA, requires highly specialized protocols, increasing the need for customized solutions. Regulatory challenges and standardization issues further hinder clinical adoption, as laboratories must adhere to stringent compliance requirements for NGS-based diagnostics. Overcoming these challenges will require continued innovation in automation, reagent chemistry, and bioinformatics solutions to make NGS library preparation more efficient, cost-effective, and scalable for a wider range of applications.

How Are Innovations Driving the Future of NGS Library Preparation?

Technological advancements are significantly improving the efficiency and accuracy of NGS library preparation, addressing key challenges in sample processing and sequencing quality. One of the most impactful innovations is the automation of library preparation workflows, reducing hands-on time, minimizing human error, and increasing sample throughput. Robotic liquid handling systems and microfluidic platforms are streamlining the preparation process, making high-throughput sequencing more accessible to clinical and research laboratories. The development of transposase-based library preparation methods, such as Illumina’s Nextera technology, is simplifying DNA fragmentation and adapter insertion, reducing preparation time and reagent costs. Additionally, single-tube and direct RNA sequencing approaches are eliminating the need for complex workflows, improving efficiency in transcriptomics studies. Advances in molecular barcoding and unique molecular identifiers (UMIs) are enhancing sequencing accuracy by reducing PCR bias and detecting low-frequency variants. The integration of AI and machine learning in bioinformatics is also optimizing library preparation protocols by predicting optimal reagent conditions and improving data interpretation. As these innovations continue to evolve, the NGS library preparation market is poised for greater efficiency, scalability, and clinical adoption.

What Is Driving the Growth of the NGS Library Preparation Market?

The growth in the next-generation sequencing library preparation market is driven by several factors, including increasing demand for personalized medicine, expanding applications of NGS in disease research, and technological advancements in automation and reagent chemistry. The growing adoption of NGS-based diagnostics in oncology, infectious diseases, and rare genetic disorders is fueling demand for more efficient and cost-effective library preparation solutions. The rise of single-cell sequencing is also contributing to market growth, as researchers require specialized library preparation methods to analyze individual cells with high sensitivity. Additionally, the expansion of agricultural genomics, microbiome studies, and synthetic biology is further driving market demand, as these fields rely on high-throughput sequencing for genomic analysis. The push for standardization and regulatory approvals for clinical NGS applications is also shaping market trends, with manufacturers developing compliant library preparation kits that meet stringent diagnostic requirements. Investments in bioinformatics and cloud-based sequencing platforms are enhancing data management and accessibility, making NGS more widely available for diverse research and clinical applications. As advancements in sequencing technologies continue to lower costs and improve accuracy, the NGS library preparation market is expected to witness sustained growth, revolutionizing genomic research and precision medicine.

SCOPE OF STUDY:

The report analyzes the Next-generation Sequencing Library Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Next-generation Sequencing Library Preparation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Precision Medicine Initiatives Throws the Spotlight on Customized NGS Library Preparation Solutions
    • Rapid Growth of Clinical Diagnostics Strengthens Business Case for Automation in Library Preparation Workflows
    • Increasing Focus on Genomic Surveillance Accelerates Demand for High-Throughput NGS Library Prep Kits
    • Rising Investments in Cancer Genomics Propels Growth of Targeted Sequencing Library Preparation Products
    • Expansion of Population Genomics Programs Expands Addressable Market Opportunity for Large-Scale Library Prep Platforms
    • Adoption of AI and Machine Learning in Genomic Data Analysis Spurs Demand for Standardized, High-Quality Library Prep Methods
    • Growing Use of Liquid Biopsy Technologies Drives Adoption of Ultra-Sensitive Library Preparation Protocols
    • Regulatory Push for Validated and Reproducible Clinical Assays Strengthens Business Case for Commercial NGS Library Kits
    • Integration of Automation and Robotics in Lab Workflows Drives Efficiency and Reduces Human Error in Library Preparation
    • Increasing Demand for Decentralized Testing Models Spurs Development of Point-of-Care Compatible Library Prep Technologies
    • Rising Demand for Epigenetic and Transcriptomic Studies Expands Scope for Specialized Library Preparation Solutions
    • Advancements in Long-Read Sequencing Technologies Drives Innovation in Compatible Library Preparation Reagents
    • Continuous Decline in Sequencing Costs Sustains Growth Momentum Across Research and Clinical Applications
    • Strategic Collaborations Between Pharma and Genomics Firms Fuel Adoption of Scalable NGS Library Preparation Platforms
    • Expansion of Biobanking and Genomic Data Repositories Generates Long-Term Demand for Reliable Library Prep Protocols
    • Transition to Cloud-Based Genomics Workflows Spurs Demand for Seamlessly Integratable Library Prep Solutions
    • Emphasis on Quality Control and Standardization Across Labs Strengthens Need for Pre-Validated Library Prep Kits
    • Accelerating Adoption of NGS in Agriculture and Microbiome Research Opens New Market Avenues for Library Preparation Products
    • Government Funding Initiatives and Genomics-Focused National Programs Drive Regional Market Penetration and Adoption
    • Intensifying Competitive Landscape Spurs Innovation in Fast, Cost-Effective, and Scalable Library Preparation Technologies
    • Emergence of Single-Cell Sequencing Drives Demand for Ultra-Low Input and Specialized Library Prep Workflows
    • Growing Importance of Data Privacy and Compliance Creates Challenges in Adoption of Cloud-Linked NGS Prep Systems
    • Movement Toward Personalized Wellness and Preventive Healthcare Expands Market Opportunity for Consumer-Directed Library Prep Solutions
    • Increasing Academia-Industry Collaborations Propels Development of Customizable and Niche Library Preparation Technologies
    • Shift Toward Multiplexed and Multi-Omic Sequencing Accelerates Innovation in Versatile Library Prep Protocols
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Next-generation Sequencing Library Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Targeted Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Targeted Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Sequencing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Sequencing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Reproductive Health Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Infectious Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Disease Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Disease Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Drug & Biomarker Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Drug & Biomarker Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Cancer Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Academic & Research Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Academic & Research Institutions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Library Preparation Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Library Preparation Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Library Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Library Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 36: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • JAPAN
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • CHINA
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • EUROPE
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • FRANCE
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 78: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • GERMANY
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • ITALY
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • UNITED KINGDOM
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 102: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030

IV. COMPETITION